International evidence‐based guideline on assessment and management of PCOS—A Nordic perspective
Abstract Polycystic ovary syndrome (PCOS) affects about 12% of women of reproductive age. In 2018, the first evidence‐based guideline on assessment and management of PCOS was published, and an updated extended guideline was released in August 2023. These guidelines followed best practice and are end...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Acta Obstetricia et Gynecologica Scandinavica |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/aogs.14725 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849687646309187584 |
|---|---|
| author | Maria Forslund Johanna Melin Elisabet Stener‐Victorin Angelica Linden Hirschberg Helena Teede Eszter Vanky Terhi Piltonen |
| author_facet | Maria Forslund Johanna Melin Elisabet Stener‐Victorin Angelica Linden Hirschberg Helena Teede Eszter Vanky Terhi Piltonen |
| author_sort | Maria Forslund |
| collection | DOAJ |
| description | Abstract Polycystic ovary syndrome (PCOS) affects about 12% of women of reproductive age. In 2018, the first evidence‐based guideline on assessment and management of PCOS was published, and an updated extended guideline was released in August 2023. These guidelines followed best practice and are endorsed by 39 organizations worldwide, making them the most robust source of evidence to guide clinical practice. In the 2023 guideline, diagnostic criteria have been further refined as polycystic ovary morphology can now be assessed with gynecological ultrasound or elevated anti‐Müllerian hormone levels. A healthy lifestyle should be at the focus of care for all women with PCOS; however, with no specific diet or physical exercise recommended. The latest evidence on medical treatments and fertility management are reviewed, including special considerations regarding long‐term follow‐up of metabolic and psychiatric comorbidities and pregnancy in women with PCOS. Here we summarize the recommendations from a Nordic perspective. |
| format | Article |
| id | doaj-art-1b2f87e020d54015adc70dc4130f3eee |
| institution | DOAJ |
| issn | 0001-6349 1600-0412 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Acta Obstetricia et Gynecologica Scandinavica |
| spelling | doaj-art-1b2f87e020d54015adc70dc4130f3eee2025-08-20T03:22:16ZengWileyActa Obstetricia et Gynecologica Scandinavica0001-63491600-04122024-01-01103171210.1111/aogs.14725International evidence‐based guideline on assessment and management of PCOS—A Nordic perspectiveMaria Forslund0Johanna Melin1Elisabet Stener‐Victorin2Angelica Linden Hirschberg3Helena Teede4Eszter Vanky5Terhi Piltonen6Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy University of Gothenburg Gothenburg SwedenDepartment of Obstetrics and Gynecology University of Helsinki, Helsinki University Hospital Helsinki FinlandDepartment of Physiology and Pharmacology Karolinska Institutet Stockholm SwedenDepartment of Women's and Children's Health Karolinska Institutet Stockholm SwedenMonash Centre for Health Research & Implementation, Faculty of Medicine, Nursing and Health Sciences Monash University Melbourne Victoria AustraliaDepartment of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences Norwegian University of Science and Technology Trondheim NorwayDepartment of Obstetrics and Gynecology, Research Unit of Clinical Medicine University of Oulu and Oulu University Hospital Oulu FinlandAbstract Polycystic ovary syndrome (PCOS) affects about 12% of women of reproductive age. In 2018, the first evidence‐based guideline on assessment and management of PCOS was published, and an updated extended guideline was released in August 2023. These guidelines followed best practice and are endorsed by 39 organizations worldwide, making them the most robust source of evidence to guide clinical practice. In the 2023 guideline, diagnostic criteria have been further refined as polycystic ovary morphology can now be assessed with gynecological ultrasound or elevated anti‐Müllerian hormone levels. A healthy lifestyle should be at the focus of care for all women with PCOS; however, with no specific diet or physical exercise recommended. The latest evidence on medical treatments and fertility management are reviewed, including special considerations regarding long‐term follow‐up of metabolic and psychiatric comorbidities and pregnancy in women with PCOS. Here we summarize the recommendations from a Nordic perspective.https://doi.org/10.1111/aogs.14725evidence‐based guidelineNordic guidelinepolycystic ovary syndrome |
| spellingShingle | Maria Forslund Johanna Melin Elisabet Stener‐Victorin Angelica Linden Hirschberg Helena Teede Eszter Vanky Terhi Piltonen International evidence‐based guideline on assessment and management of PCOS—A Nordic perspective Acta Obstetricia et Gynecologica Scandinavica evidence‐based guideline Nordic guideline polycystic ovary syndrome |
| title | International evidence‐based guideline on assessment and management of PCOS—A Nordic perspective |
| title_full | International evidence‐based guideline on assessment and management of PCOS—A Nordic perspective |
| title_fullStr | International evidence‐based guideline on assessment and management of PCOS—A Nordic perspective |
| title_full_unstemmed | International evidence‐based guideline on assessment and management of PCOS—A Nordic perspective |
| title_short | International evidence‐based guideline on assessment and management of PCOS—A Nordic perspective |
| title_sort | international evidence based guideline on assessment and management of pcos a nordic perspective |
| topic | evidence‐based guideline Nordic guideline polycystic ovary syndrome |
| url | https://doi.org/10.1111/aogs.14725 |
| work_keys_str_mv | AT mariaforslund internationalevidencebasedguidelineonassessmentandmanagementofpcosanordicperspective AT johannamelin internationalevidencebasedguidelineonassessmentandmanagementofpcosanordicperspective AT elisabetstenervictorin internationalevidencebasedguidelineonassessmentandmanagementofpcosanordicperspective AT angelicalindenhirschberg internationalevidencebasedguidelineonassessmentandmanagementofpcosanordicperspective AT helenateede internationalevidencebasedguidelineonassessmentandmanagementofpcosanordicperspective AT esztervanky internationalevidencebasedguidelineonassessmentandmanagementofpcosanordicperspective AT terhipiltonen internationalevidencebasedguidelineonassessmentandmanagementofpcosanordicperspective |